Literature DB >> 27900675

SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.

Ravindra Pramod Deshpande1, Y B V K Chandra Sekhar2, Manas Panigrahi2, Phanithi Prakash Babu3.   

Abstract

Astrocytomas are the most common brain tumors with poor survival in malignant forms. Signal regulatory protein alpha (SIRP alpha) is a transmembrane protein expressed on immune cells and macrophages and is reported to modulate tumor cell phagocytosis. In the present study, we investigated the involvement of miR-520d-5p and miR-520d-3p in regulation of SIRP alpha expression. Here, we report mRNA and protein expression profile of SIRP alpha in 39 surgically resected human astrocytoma tissue samples and 14 control brain tissue samples. Transcript expression pattern was studied by real-time PCR while Western blotting and immunohistochemistry were used to evaluate protein expression. Expression profile of miR-520d-5p and miR-520d-3p was studied by real-time PCR. Computational prediction was employed to analyze the binding of miR-520d-5p and miR-520d-3p for SIRP alpha mRNA. It is evident from preliminary investigation that SIRP alpha transcripts are expressed in control brain tissues, increased in low-grade (grade II) tumor tissues, and decreased with further grade progression (P < 0.05). SIRP alpha protein was moderately expressed in control brain tissues but under-expressed in low- and high-grade tissue samples (P < 0.05). Immunohistochemistry results further confirmed Western blot outcomes. Computational prediction supplemented with 3' and 5'UTR targeting analysis and correlation studies reveals that hsa-miR-520d-5p (P = 0.028, R 2 = 0.94) (95 % CI 0.15 to 0.99) and hsa-miR-520d-3p (P = 0.027, R 2 = 0.94) (95% CI 0.17 to 0.99) may be the putative microRNAs involved in regulation of SIRP alpha protein expression. Real-time PCR expression profile depicts that mature form of both miRNAs is significantly overexpressed in low-grade (GII) tumor tissue samples compared to control and high-grade (GIII and GIV) tissue samples. MiR-520d-5p and miR-520d-3p were found with expression pattern similar to SIRP alpha transcripts. We show that SIRP alpha protein is under-expressed in low and high grades of astrocytoma patients' tissue samples. Control brain tissues were found to be positive with SIRP alpha protein expression. Real-time PCR expression analysis confirms that miR-520d-5p and miR-520d-3p expression levels were significantly correlated with SIRP alpha transcripts in control, low-grade, and high-grade tissue samples. Computational prediction further evidenced for binding sites of these miRNAs on 3' and 5'UTR of SIRP alpha transcripts. Taken together, we predict that miR-520d-5p and miR-520d-3p may be having role in the regulation of under-expressed SIRP alpha protein expression.

Entities:  

Keywords:  Astrocytoma; Glioblastoma; SIRP alpha; miR-20d-5p; miR-520d-3p; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27900675     DOI: 10.1007/s12035-016-0302-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).

Authors:  C J Wu; Z Chen; A Ullrich; M I Greene; D M O'Rourke
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

3.  MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.

Authors:  Lihua Sun; Wei Yan; Yingyi Wang; Guan Sun; Hui Luo; Junxia Zhang; Xiefeng Wang; Yongping You; Zhengxiang Yang; Ning Liu
Journal:  Brain Res       Date:  2011-03-16       Impact factor: 3.252

4.  CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1.

Authors:  E F Vernon-Wilson; W J Kee; A C Willis; A N Barclay; D L Simmons; M H Brown
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

5.  A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion.

Authors:  Y Fujioka; T Matozaki; T Noguchi; A Iwamatsu; T Yamao; N Takahashi; M Tsuda; T Takada; M Kasuga
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

6.  Expression and activation of signal regulatory protein alpha on astrocytomas.

Authors:  Thomas T Chen; Eric J Brown; Eric J Huang; William E Seaman
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

7.  Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffin-embedded samples.

Authors:  Adrienn Gyongyosi; Otto Docs; Zsolt Czimmerer; Laszlo Orosz; Attila Horvath; Olga Török; Gabor Mehes; Laszlo Nagy; Balint L Balint
Journal:  Methods Mol Biol       Date:  2014

8.  Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs.

Authors:  Erika Varkonyi-Gasic; Rongmei Wu; Marion Wood; Eric F Walton; Roger P Hellens
Journal:  Plant Methods       Date:  2007-10-12       Impact factor: 4.993

9.  Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model.

Authors:  Yoshitaka Ishihara; Satoshi Tsuno; Satoshi Kuwamoto; Taro Yamashita; Yusuke Endo; Keigo Miura; Yugo Miura; Takemasa Sato; Junichi Hasegawa; Norimasa Miura
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more
  3 in total

1.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

2.  p62 acts as an oncogene and is targeted by miR-124-3p in glioma.

Authors:  Danni Deng; Kaiming Luo; Hongmei Liu; Xichen Nie; Lian Xue; Rong Wang; Yuan Xu; Jun Cui; Naiyuan Shao; Feng Zhi
Journal:  Cancer Cell Int       Date:  2019-11-06       Impact factor: 5.722

3.  SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis.

Authors:  Fengping Du; Qian Hou
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.